Farzadi Laya, Khayatzadeh Bidgoli Homa, Ghojazadeh Morteza, Bahrami Zahra, Fattahi Amir, Latifi Zeinab, Shahnazi Vahideh, Nouri Mohammad
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Liver and Gastrointestinal Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Iran J Reprod Med. 2015 Jun;13(6):361-6.
Vitamin D in complex with its receptor by regulating gene expression, endometrium immune response and stimulation of endometrium decidualization can be involved in implantation. So, it seems that the amount of vitamin D in follicular fluids (FF) may have an association with ART success.
First, we intended to investigate the possible association between levels of follicular fluids 25-OH vitamin D with assisted reproductive outcomes. Second, we examined relationship between 25-OH vitamin D levels with number and quality of oocytes.
In a prospective study, 80 infertile female candidates for IVF/ICSI were enrolled. Blood samples (on the day of human chorionic gonadotropin administration) and follicular fluids were taken, and then levels of serum estradiol and follicular fluids 25-OH vitamin D were measured. Also clinical characteristics of patients (duration of infertility, causes of infertility, menstrual status), number and quality of oocytes, number of fertilized oocytes, estradiol levels, and clinical pregnancy were evaluated.
Concentration of FF 25-OH vitamin D in pregnant women was significantly higher than non-pregnant women (p=0.007) but there were no significant differences in age, body mass index (BMI), duration of infertility, menstrual status, number of oocytes, oocytes quality, number of fertilized oocytes, and serum estradiol levels between the two groups. Statistically positive correlation was found between 25-OH vitamin D levels with patient age and implantation rate (r=0.264, p=0.018 and r=0.301, p=0.007 respectively).
The obtained results suggest that vitamin D without affecting the number and quality of oocytes can independently improve implantation rate and IVF outcome.
维生素D与其受体结合,通过调节基因表达、子宫内膜免疫反应和刺激子宫内膜蜕膜化参与着床过程。因此,卵泡液(FF)中维生素D的含量可能与辅助生殖技术的成功率有关。
首先,我们旨在研究卵泡液中25-羟基维生素D水平与辅助生殖结局之间的可能关联。其次,我们研究了25-羟基维生素D水平与卵母细胞数量和质量之间的关系。
在一项前瞻性研究中,招募了80名接受体外受精/卵胞浆内单精子注射的不孕女性。采集血样(在注射人绒毛膜促性腺激素当天)和卵泡液,然后测量血清雌二醇水平和卵泡液中25-羟基维生素D水平。此外,还评估了患者的临床特征(不孕持续时间、不孕原因、月经状况)、卵母细胞数量和质量、受精卵数量、雌二醇水平以及临床妊娠情况。
孕妇卵泡液中25-羟基维生素D的浓度显著高于未孕女性(p = 0.007),但两组在年龄、体重指数(BMI)、不孕持续时间、月经状况、卵母细胞数量、卵母细胞质量、受精卵数量和血清雌二醇水平方面无显著差异。25-羟基维生素D水平与患者年龄和着床率之间存在统计学上的正相关(分别为r = 0.264,p = 0.018和r = 0.301,p = 0.007)。
所得结果表明,维生素D在不影响卵母细胞数量和质量的情况下,可独立提高着床率和体外受精结局。